Kevin Perhamus, an officer of Arxis, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 25,000 common shares through Goldman Sachs & Co. LLC under a Rule 10b5-1 trading plan.

Key Highlights

  • Seller and role: Kevin Perhamus, identified as an officer of Arxis, Inc., is the person for whose account the securities are to be sold.
  • Shares proposed for sale: 25,000 common shares with an aggregate market value of $1,256,500, according to the filing.
  • Shares outstanding: The filing reports 90,045,099 common shares outstanding.
  • Acquisition origin: The shares were acquired on May 6, 2026, as compensation through Restricted Stock Awards granted by Arxis, Inc.
  • Approximate sale date: November 9, 2026, through Goldman Sachs & Co. LLC, located at 200 West Street, New York, NY 10282.
  • 10b5-1 plan: The filing states the sales "are made in connection with a selling plan dated 8/10/2026, that is intended to comply with Rule 10b5-1(c)."
  • Prior sales: The filing reports nothing to report under securities sold during the past 3 months.

Arxis Officer Files Notice of Proposed Share Sale Under 10b5-1 Plan

According to the Form 144 filing submitted on November 9, 2026, Kevin Perhamus, an officer of Arxis, Inc. (NASD, SEC File Number 001-43234), intends to sell 25,000 common shares of the company. The filing lists the aggregate market value of the proposed sale at $1,256,500, with 90,045,099 total common shares reported as outstanding at the time of notice.

The shares proposed for sale were acquired on May 6, 2026, through Restricted Stock Awards granted by Arxis, Inc., with the nature of payment described as compensation. The filing designates Goldman Sachs & Co. LLC as the named broker for the transaction, with the approximate date of sale listed as November 9, 2026. Arxis, Inc. is headquartered at 1332 Blue Hills Avenue, Bloomfield, Connecticut 06002.

The filing notes that the proposed sale is conducted under a written selling plan dated August 10, 2026, described as "intended to comply with Rule 10b5-1(c)" under the Securities Exchange Act. The date of plan adoption is listed as August 10, 2026. The filing also discloses that no securities of the issuer were sold by Perhamus in the three months preceding this notice.

What Was Disclosed

Arxis, Inc. officer Kevin Perhamus filed a Form 144 on November 9, 2026, proposing the sale of 25,000 common shares acquired as restricted stock awards, with an aggregate market value of $1,256,500, through Goldman Sachs & Co. LLC under a Rule 10b5-1 plan adopted August 10, 2026.